Pi Pharma Intelligence’s Contributions Extend Beyond the Pharmaceutical Industry to Include Academia
AchievementWe are glad to see Pi Pharma Intelligence rising as a trusted provider of data, Today marks our first contribution to an article published at the Annals of Pharmacotherapy on Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma with BRAF Mutation, we thank all the authors for their trust and special thanks to our advisor Dr.Nimer Alkhatib
Pi Pharma Intelligence has been recognized as one of the Top 10 Pioneers in Pharma Pre-Marketing insights
Oct, 2024
We are thrilled to announce that Pi Pharma Intelligence has been recognized as one of the Top 10 Pioneers in Pharma Pre-Marketing insights across the Middle East by Insights Success Global for February 2024
"Empowering Future Leaders: Pi Pharma's Transformative Communication Skills Training"
May, 2024
"Empowering Future Leaders: Pi Pharma's Transformative Communication Skills Training"
Kexing Biopharm Representatives Meet with Pi Pharma Intelligence Executives to discuss access strategies in MENA region
Oct, 2022
Kexing Biopharm Representatives Meet with Pi Pharma Intelligence Executives to discuss access strategies in MENA region